abs404.txt	background	&	aims		guidelines	recommend	endoscopic	surveillance	of	patients	withbarrett's	esophagus	(be)	to	identify	those	with	dysplasia	(a	precursor	ofcarcinoma)	or	early-stage	esophageal	adenocarcinoma	(eac)	who	can	be	treatedendoscopically	however	it	is	unclear	whether	increases	survivaltimes	we	performed	a	systematic	review	and	meta-analysis	toqualitatively	quantitatively	examine	evidence	for	the	association	ofendoscopic	in	survival	other	outcomes	methods	searched	publication	databases	studies	reporting	effects	on	mortality	eac-related	reviewedrandomized	controlled	trials	case-control	comparing	patientswith	received	regular	did	not	receive	regularsurveillance	withsurveillance-detected	eac	vs	symptom-detected	eacs	meta-analysisof	generate	summary	estimates	using	random	effectsmodel	primary	aim	was	oneac-related	secondary	were	besurveillance	all-cause	stage	at	time	diagnosis	results	single	study	show	any	betweensurveillance	4	cohort	foundthat	lower	associated	(relative	risk	0	60	95%	ci	50-0	71	hazard	ratio	75	59-0	94)	12	showed	andall-cause	among	surveillance-detected	vssymptom-detected	73	57-0	94	59	45-0	76)	lead-	length-time	bias	adjustment	substantiallyattenuated/eliminated	observed	benefits	withdetection	earlier	stages	randomized	trial	underway	evaluatethe	conclusions	ofsurveillance	as	currently	wasassociated	detection	earlier-stage	may	provide	small	survivalbenefit	confounding	biases	these	are	notfully	defined	completely	partially	explain	differencesbetween	surveyed	unsurveyed
